Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Cancer Biomarkers Licenses Chinese Rights to Colorectal Cancer Tests

NEW YORK (GenomeWeb) – Oxford Cancer Biomarkers (OCB) announced today that it has licensed its suite of in vitro colorectal cancer diagnostics to Chinese precision medicine firm My-BioMed Biotechnology (MBM).

Under the terms of the deal, MBM will have access to OCB's ColoTox, ColoProg, and ColoPredict tests and technologies, which will be offered in China through a purpose-built biomedical laboratory. Additional terms were not disclosed.

ColoTox is designed to predict a patient's risk of life-threatening toxicity from fluoropyrimidine-based chemotherapy by analyzing germline DNA for the presence of risk alleles. ColoProg is performed after colorectal cancer surgery to stratify a patient's risk for relapse based on various genetic biomarkers, and ColoPredict identifies healthy individuals at increased risk for developing colorectal cancer by analyzing DNA collected from a mouth swab.

"We are looking forward to working closely with MBM to tailor our offerings to the specific needs of the Chinese market and building a robust product pipeline of diagnostics specifically aimed at the Chinese population," OCB Chief Medical Officer David Kerr said in a statement. "This is an important step in our mission to drive global access to technologies that allow patient stratification and individually tailored treatment pathways."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.